AdvanCell Isotopes Pty Ltd

0 followers


AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.

Industries

+1

Stage

Employees

Links

Org chart

Andrew Adamovich
Chief Executive Officer

Andrew Adamovich

Collapse
Julian F. Kelly
Chief Scientist (Nuclear & Chemical)
Kevin Kuan
SVP Technical Operations
Nicolò Canever
Materials Development Manager
Sheridan Martin
Facilities Manager And Head Radiation Safety Officer
Thomas Kryza
Head Of Preclinical Development
Vanessa Worsfold
Head Of Quality And Head Of Marketing
Sheruna Naidoo
Head Of Quality And Regulatory Affairs
Michael Tung
Chief Financial Officer